CONNECT WITH US
HealthTech

HealthTech

Lab-grown blood vessels reveal roles of different cells in rapid-aging disease

Medical Xpress logo

Published on

Add as a preferred source on Google
Lab-grown blood vessels reveal roles of different cells in rapid-aging disease

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Biomedical engineers at Duke University have developed a three-layer model of human blood vessels that enables researchers to better understand how Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder that causes accelerated aging, affects the vascular system.

By combining three major types of cells found in blood vessel walls, this new model allows researchers to more comprehensively study how certain cells are affected by HGPS and explore how they respond to new therapies. The work is published in Science Advances.

HGPS is an extremely rare, fatal disease that causes accelerated aging in children. The condition is triggered by a random gene mutation, and children with it typically die in their teens or early 20s, often from cardiovascular complications like heart disease or stroke. But these complications don't arise from the typical drivers of cardiovascular disease, such as high cholesterol and the subsequent formation of artery-clogging plaques. Instead, blood vessels in people with HGPS undergo major structural changes, including the loss of smooth muscle cells and increased stiffness.

To better understand how and why these changes were occurring in HGPS, George Truskey, the R. Eugene and Susie E. D. graduate from the Truskey lab, built on an earlier tissue-engineered blood vessel model containing endothelial and smooth muscle cells by adding a third cell layer made from fibroblasts.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.